MedPath

Association between posaconazole use and hypokalemia: A Systematic Review and Meta-Analysis

Not Applicable
Conditions
Patients with prophylactic administration of posaconazole for invasive fungal infections in severely immunocompromised states such as hematopoietic stem cell transplantation or hematologic malignancies where neutropenia is predicted Patients treated with posaconazole for invasive aspergillosis, fusariosis, mucormycosis, coccidioidosis, chromoblastomycosis, and mycetoma Patients treated with posaconazole for oropharyngeal candidiasis The trial will be a randomised controlled trial with the above subjects
Registration Number
JPRN-UMIN000052316
Lead Sponsor
Saiseikai Futsukaichi Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Letters/correspondence, case reports, relevant reviews, no controlled arm, unclear outcomes

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath